NEW YORK & STOCKHOLM--(BUSINESS WIRE)-- Essity (STO: ESSITY-B) has selected Accenture (ACN) and Microsoft to help the global hygiene and health company accelerate the use of AI agents to unlock value ...
The company's financial targets include annual organic sales growth of 3% or above and EBITDA margins of 15% or above, with a focus on optimizing the portfolio and cost savings. Essity is viewed as an ...
In terms of grant share, Essity stands in fifth position among its competitors. Procter & Gamble and Unicharm secured the top positions according to recent patent publication data. Patents related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results